Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "BJU International"
DOI: 10.1111/bju.14948
Abstract: To report clinical outcomes of the Hemi‐Ablative Prostate Brachytherapy (HAPpy) trial evaluating treatment‐related toxicity and effectiveness of hemi‐gland (HG) low‐dose‐rate (LDR) prostate brachytherapy as a focal approach to control unilateral localised prostate cancer. read more here.
Keywords: prostate; low dose; prostate brachytherapy; unilateral localised ... See more keywords